Evidence map›Paper›PMID 38393350›Full record

ArticleApplied microbiology and biotechnology2024

A new and promiscuous α/β hydrolase from Acinetobacter tandoii DSM 14970

Ana Sánchez-Arroyo, Laura Plaza-Vinuesa, María Claudia Abeijón-Mukdsi, Blanca de Las Rivas, José Miguel Mancheño, Rosario Muñoz

Open access · goldAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Journal of agricultural and food chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ana Sánchez-ArroyoBacterial Biotechnology, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 6, 28040, Madrid, Spain.
Laura Plaza-VinuesaBacterial Biotechnology, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 6, 28040, Madrid, Spain.
María Claudia Abeijón-MukdsiBacterial Biotechnology, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 6, 28040, Madrid, Spain.
Blanca de Las RivasBacterial Biotechnology, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 6, 28040, Madrid, Spain.
José Miguel MancheñoDepartment of Crystallography and Structural Biology, Institute of Physical Chemistry Blas Cabrera, CSIC, Serrano 119, 28006, Madrid, Spain. jm.mancheno@csic.es.ORCID http://orcid.org/0000-0001-6943-3291
Rosario MuñozBacterial Biotechnology, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 6, 28040, Madrid, Spain. r.munoz@csic.es.
Instituto de Ciencia y Tecnología de Alimentos y Nutrición · ESConsejo Superior de Investigaciones Científicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of ochratoxin A (OTA) in food and feed represents a serious concern since it raises severe health implications. Bacterial strains of the Acinetobacter genus hydrolyse the amide bond of OTA yielding non-toxic OTα and L-β-phenylalanine; in particular, the carboxypeptidase PJ15_1540 from Acinetobacter sp. neg1 has been identified as an OTA-degrading enzyme. Here, we describe the ability to transform OTA of cell-free protein extracts from Acinetobacter tandoii DSM 14970

Indexed as

AcinetobacterMycotoxinsOchratoxinsAmidesCarboxypeptidasesEsterasesHydrolasesMolecular Docking SimulationAmidesCarboxypeptidasesEsterasesHydrolasesMycotoxinsochratoxin AOchratoxinsAmidohydrolaseEsteraseMycotoxinOchratoxin APromiscuous enzymes

Identifiers

PMID38393350
PMCPMC10891195
OpenAlexW4392122799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.